Sterilization of plga microspheres containing rasagiline mesylate destined to treat parkinson’s disease
- At: 2010 FIP Congress in Lisbon (Portugal)
- Type: Poster
- By: FERNáNDEZ, Marcos (Universidad Complutense de Madrid, Madrid, Spain)
- Co-author(s): Barcia, Emilia (Universidad Complutense de Madrid, MADRID, Spain)
Torres-Suárez, Ana Isabel (Universidad Complutense de Madrid, MADRID, Spain)
Negro, Sofía (Universidad Complutense de Madrid, MADRID, Spain)
BACKGROUND Rasagiline mesylate (RM) is a selective MAO-B inhibitor used in Parkinson's disease. Long term drug delivery devices, such as microspheres, can be beneficial in chronic therapies. Microspheres for parenteral administration have to meet the pharmacopoeial requirements of sterility. In our study, the influence of Î³-sterilization was.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.